Page last updated: 2024-11-12
fagopyritol b1
Description
fagopyritol B1: isolated from buckwheat; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
fagopyritol B1 : An alpha-D-galactoside that is 1D-chiro-inositol having an alpha-D-galactosyl residue attached at position 2 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 9906026 |
CHEBI ID | 133330 |
SCHEMBL ID | 5670772 |
MeSH ID | M0290872 |
Synonyms (10)
Synonym |
o-alpha-d-galactopyranosyl-(1->2)-1d-chiro-inositol |
2-o-alpha-d-galactopyranosyl-d-chiro-inositol |
fagopyritol b1 |
(1s,2s,3r,4r,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl alpha-d-galactopyranoside |
o-alpha-d-galactosyl-(1->2)-1d-chiro-inositol |
CHEBI:133330 |
2-o-alpha-d-galactosyl-d-chiro-inositol |
SCHEMBL5670772 |
(1s,2r,4r,5s)-6-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexane-1,2,3,4,5-pentol |
VCWMRQDBPZKXKG-KZMAIVIWSA-N |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.36 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.31 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |